Search

everythinglearnresearchcommunity

for

Search:↓

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Finasteride reduces movement issues in Parkinson's disease rats.

Finasteride caused enlarged breast tissue in a 62-year-old man.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Gene differences found in hair follicles linked to male baldness.